## TSLA: Tesla, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 3.7% below STRENGTH zone (4.0-10.0%); PEG 9.49 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($409.32)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 1, Bearish: 6)

**1. Michael Burry Says Tesla Is ‘Ridiculously Overvalued.’ Should You Ditch TSLA Stock Here?**
- Source: Barchart.com | 20251203T201000 | Bearish | Relevance: 100%
- The article discusses Michael Burry's assertion that Tesla (TSLA) is "ridiculously overvalued" due to contracting EV deliveries and significant lags in the robotaxi race. The author agrees with Burry, citing the unproven value of Tesla's robots and past failures of Elon Musk's grandiose plans. It recommends investors sell TSLA stock given the competition and the company's valuation metrics.

**2. Gains for Tesla offset drop in other 'Magnificent Seven' stocks**
- Source: MarketWatch | 20251203T182340 | Somewhat-Bullish | Relevance: 100%
- Tesla Inc. shares saw a significant climb, helping to maintain a popular exchange-traded fund tracking the "Magnificent Seven" megacap tech stocks in positive territory. This gain for Tesla offset declines experienced by several other major tech companies including Microsoft, Amazon, Nvidia, Meta Platforms, and Apple. Meanwhile, Google's parent company, Alphabet Inc., also recorded a modest increase in its stock value.

**3. Tesla just posted rare growth in China. Here’s what sparked the sales momentum.**
- Source: MarketWatch | 20251202T161600 | Bullish | Relevance: 100%
- Tesla experienced a rare surge in sales growth in China during November, making it the second-best performance in 2025 by units sold. This sales momentum was driven by new trims of its best-selling models, resulting in 86,700 China-made EVs sold. This growth is significant as it marks only the third month this year Tesla has seen sales growth in the major EV market, despite FactSet consensus indicating a projected global delivery decline for 2025 compared to previous years.

**4. Tesla Stock Today (TSLA): Michael Burry’s New Short, China Sales Jump and 2026 Robotaxi Bets – December 2, 2025**
- Source: ts2.tech | 20251202T135116 | Neutral | Relevance: 100%
- This article examines Tesla (TSLA) stock as of December 2, 2025, detailing Michael Burry's renewed short position and criticism of its valuation, alongside strong China sales and bullish analyst projections for robotaxis. It highlights Tesla's status as a polarizing stock, facing slow auto growth and margin pressure but holding significant long-term potential in AI and autonomy. The piece dissects the bear and bull cases, regional performance, and key debates driving TSLA's volatile valuation.

**5. Tesla China Shipments Rise for Just the Third Time This Year**
- Source: Bloomberg.com | 20251202T121500 | Somewhat-Bullish | Relevance: 100%
- Tesla's China plant experienced a shipment increase for only the third time this year, amid a broader global sales downturn for the company. In November, 86,700 vehicles were shipped from its Shanghai factory, marking a 10% rise year-over-year and representing the second-highest monthly total for Tesla in China this year.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-25 | Mizuho | $475 | $485 | -2% |
| 2025-11-17 | Stifel | $508 | $483 | +5% |
| 2025-11-07 | Wedbush | $600 | $600 | 0% |
| 2025-11-05 | Wedbush | $600 | $600 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-25 | Mizuho | main | Outperform |
| 2025-11-17 | Stifel | main | Buy |
| 2025-11-07 | Wedbush | reit | Outperform |
| 2025-11-05 | Wedbush | reit | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($141568.60M) |
| Sells | 3 ($1.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 26.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 7.6% (+0.4%)
- Blackrock Inc.: 6.2% (+0.4%)
- State Street Corpora: 3.4% (+0.3%)
- JPMORGAN CHASE & CO: 2.7% (+94.0%)
- Geode Capital Manage: 2.0% (+0.9%)

### Key Risks

1. High beta (1.88) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Valuation stretched: PEG 9.5x requires aggressive growth execution.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +4.3% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 9.49 signals overvaluation risk, limited margin of safety. Forward P/E 202.3x stretched relative to 35% growth. Balance sheet: strong liquidity (2.1x), $4.0B free cash flow. Insider buying signal ($141568.6M), management confidence. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $1580.4B |
| Beta | 1.88 |
| 52W Range | $214.25 - $498.83 |
| Short Interest | 2.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 9.49 |
| Forward P/E | 202.3 |
| Current P/E | 272.8 |
| YoY Growth | 34.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.6% to 3.7% (+4.3% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.3pp (needs >4.0% for momentum thesis). MRS_5 at 2.8% confirms short-term momentum alignment. AM_20 at 5.6% shows strong absolute momentum above own 20MA. Outperforming sector by 3.0pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (3.36), confirming momentum. RSI neutral at 58. OFD pattern: +FTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.70% (CS: 82) | Neutral |
| RSI_14 | 58.4 | Neutral |
| MACD Histogram | 3.36 | Bullish |
| vs SMA20 | 1.056x | Above |
| vs SMA50 | 1.029x | Above |
| vs SMA200 | 1.308x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $446.74
- **Stop Loss:** $409.32 (8.4% risk)
- **Target:** $484.16 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 30
- **Position Value:** $13,402.20
- **Portfolio %:** 13.40%
- **Risk Dollars:** $1,140.00
- **Risk Per Trade:** 1.14%
- **Modifiers:** L1 95% | L2 120% | Combined 1.14x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-01-28 (Est: $0.45)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.56 | $0.50 | -10.5% |
| 2025Q2 | $0.40 | $0.40 | -1.0% |
| 2025Q1 | $0.41 | $0.27 | -34.9% |
| 2024Q4 | $0.77 | $0.73 | -4.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*